Axsome Therapeutics, Inc.

Creative Planning AXSM

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

24,647

Value ($000)

4,502

Weight

0.0%

2019 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	4,502	0.0%	24,647	12/31/2025
2025 Q3	11/14/2025	2,584	0.0%	21,278	9/30/2025
2025 Q2	8/8/2025	1,679	0.0%	16,080	6/30/2025
2025 Q1	5/15/2025	2,031	0.0%	17,416	3/31/2025
2024 Q4	2/14/2025	1,038	0.0%	12,267	12/31/2024
2024 Q3	10/11/2024	975	0.0%	10,854	9/30/2024
2024 Q2	8/15/2024	673	0.0%	8,365	6/30/2024
2024 Q1	5/13/2024	576	0.0%	7,216	3/31/2024
2023 Q4	2/14/2024	545	0.0%	6,852	12/31/2023
2023 Q3	11/16/2023	446	0.0%	6,388	9/30/2023
2023 Q2	7/21/2023	458	0.0%	6,375	6/30/2023
2023 Q1	5/15/2023	416	0.0%	6,746	3/31/2023
2022 Q4	2/10/2023	711	0.0%	9,215	12/31/2022
2022 Q3	11/3/2022	411	0.0%	9,221	9/30/2022
2021 Q2	8/4/2021	652	0.0%	9,668	6/30/2021
2021 Q1	4/30/2021	607	0.0%	10,721	3/31/2021
2020 Q4	1/29/2021	906	0.0%	11,121	12/31/2020
2020 Q3	11/5/2020	846	0.0%	11,875	9/30/2020
2020 Q2	7/23/2020	1,485	0.0%	18,050	6/30/2020
2020 Q1	5/5/2020	613	0.0%	10,426	3/31/2020
2019 Q4	1/30/2020	1,479	0.0%	14,312	12/31/2019